Welcome to our dedicated page for Virnetx Holding SEC filings (Ticker: VHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
VirnetX Holding Corporation filings document governance, public-company status and material-event disclosures for an internet security software and technology company focused on secure communications and Zero Trust Network Access. Proxy materials cover annual meeting procedures, director and stockholder voting matters and related governance disclosures.
VirnetX's recent Form 8-K filings report Regulation FD announcements, listing-transfer matters and exhibits tied to company press releases. Form 25 records document the voluntary withdrawal of the company's common stock from listing and registration on the New York Stock Exchange, while subsequent filings identify VHC as Nasdaq-listed.
VirnetX Holding Corporation has filed a Form 25 to remove the listing and/or registration of its common stock, par value $0.0001 per share, from the New York Stock Exchange under Section 12(b) of the Securities Exchange Act of 1934. This action means the company’s common shares will no longer be listed on the NYSE once the process is completed under applicable SEC and exchange rules.
The notification is signed by Chief Executive Officer Kendall Larsen and dated September 22, 2025, formally initiating the delisting and deregistration process for the common stock.
VirnetX Holding Corporation has filed a Form 25 to remove the listing and/or registration of its common stock, par value $0.0001 per share, from the New York Stock Exchange under Section 12(b) of the Securities Exchange Act of 1934. This action means the company’s common shares will no longer be listed on the NYSE once the process is completed under applicable SEC and exchange rules.
The notification is signed by Chief Executive Officer Kendall Larsen and dated September 22, 2025, formally initiating the delisting and deregistration process for the common stock.
VirnetX Holding Corporation is moving the listing of its common stock from the New York Stock Exchange to The Nasdaq Stock Market LLC. The company notified the NYSE on September 11, 2025 that it intends to voluntarily withdraw its listing and transfer to Nasdaq.
VirnetX expects trading of its common stock on the NYSE to end at market close on or about September 22, 2025, with trading on Nasdaq beginning at market open on or about September 23, 2025. The stock has been approved for listing on Nasdaq and will continue to trade under the ticker symbol “VHC”. The company also issued a press release describing the planned transfer.
VirnetX Holding Corporation reported results for the quarter ended June 30, 2025, showing continued operating losses while maintaining a multi-month cash runway. Revenue was immaterial at $48 thousand for the six months ended June 30, 2025. Operating expenses totaled $8.0 million for the six months, driven by $2.47 million in R&D and $5.57 million in selling, general and administrative expenses.
The company recorded a six-month net loss of $7.3 million (basic loss per share $1.99), and used $6.8 million of cash in operating activities during the period. At June 30, 2025, VirnetX held $17.3 million in cash and $13.9 million of investments available for sale, totaling $31.2 million in liquid resources. Total assets were $41.8 million, total liabilities $8.6 million, and stockholders' equity $33.2 million. The company reported an accumulated deficit of $212.0 million and maintains a full valuation allowance on its deferred tax assets. Management describes ongoing commercialization efforts for VirnetX One™, War Room™, and VirnetX Matrix™, a CRADA with AFRL through 2030, and investments in AI/ML partnerships to support DoD-focused product adoption.
VirnetX Holding Corp Chief Scientist Robert D. Short III reported a Form 4 filing on June 28, 2025, disclosing transactions from June 23, 2025. The insider disposed of 8 shares of Common Stock at $8.06 per share through a withholding transaction (Code F).
Key details of the transaction:
- The shares were withheld by the company for tax purposes related to previously awarded restricted stock units
- Following the transaction, Short holds 31,898 shares directly
- Additionally owns 11,278 shares indirectly through The Short Revocable Living Trust
The transaction was executed under standard tax withholding procedures and does not represent an open market sale by the insider. The filing was signed by Kendall Larsen as attorney-in-fact for Robert D. Short III on June 25, 2025.